ArgusEye

About

ArgusEye is a biotechnology company based in Linköping, Sweden, founded in 2017 as a spin-off from Linköping University. The company specializes in advanced sensor solutions for real-time monitoring and control of biological systems in the biopharmaceutical industry. With over 15 years of academic research backing its technology, ArgusEye develops patented nanoplasmonic sensing technology combined with fiber optics. The company's flagship product is the Auga sensor system platform, which includes AugaOne, launched in March 2024. AugaOne enables real-time, in-line monitoring of critical quality attributes in monoclonal antibody process development. It can handle complex samples without pre-treatment and integrates easily into existing equipment. ArgusEye also offers customized services, including tailored sensor chip development and customer sample validation, to meet specific bioprocessing needs. The company has partnered with Bayer and serves multiple international customers for technology validation.